Trials / Conditions / Stage IIIC2 Cervical Cancer FIGO 2018
Stage IIIC2 Cervical Cancer FIGO 2018
4 registered clinical trials studyying Stage IIIC2 Cervical Cancer FIGO 2018 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Mai NCT07061977 | National Cancer Institute (NCI) | Phase 3 |
| Withdrawn | Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy NCT05093712 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer NCT04574635 | Mayo Clinic | — |
| Active Not Recruiting | A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Tria NCT04580771 | M.D. Anderson Cancer Center | Phase 2 |